Dr. Achim Brinker has a strong life sciences background in academic and biotechnology/pharma settings. His practice focuses on biotherapeutics (e.g., antibodies, antisense, vaccines), small molecule drugs, diagnostics, and genomics technologies.Achim has drafted and prosecuted domestic and foreign patent applications; conducted patentability, freedom-to-operate (FTO), and IP landscaping analyses; and contributed to opinion letters and due diligence matters. At the start of his career he worked at the Genomics Institute of the Novartis Research Foundation (GNF) in San Diego for more than six years, including as associate director of a lead discovery group. His team focused on ultra-high-throughput biology approaches to identify small molecule and genetic leads for the treatment of immune disease, infectious disease, cancer, and numerous other conditions. In this role he collaborated with scientists across Novartis's global research organization as well as several academic groups. Achim was also a postdoctoral fellow at The Scripps Research Institute for two years where he worked on the development of an "antibody chip" proteomics platform for the detection of human disease markers.